R.F.M. Maas

855 total citations
21 papers, 695 citations indexed

About

R.F.M. Maas is a scholar working on Pharmacology, Plant Science and Molecular Biology. According to data from OpenAlex, R.F.M. Maas has authored 21 papers receiving a total of 695 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmacology, 7 papers in Plant Science and 5 papers in Molecular Biology. Recurrent topics in R.F.M. Maas's work include Pharmacogenetics and Drug Metabolism (9 papers), Mycotoxins in Agriculture and Food (7 papers) and Hormonal and reproductive studies (5 papers). R.F.M. Maas is often cited by papers focused on Pharmacogenetics and Drug Metabolism (9 papers), Mycotoxins in Agriculture and Food (7 papers) and Hormonal and reproductive studies (5 papers). R.F.M. Maas collaborates with scholars based in Netherlands, Belgium and Czechia. R.F.M. Maas's co-authors include Johanna Fink‐Gremmels, Els M. de Groene, Gerben Schaaf, M.E.M. Kuilman, Peggy Roestenberg, Sandra M. Nijmeijer, Renger F. Witkamp, H. De Bosschere, Richard Ducatelle and D J Judah and has published in prestigious journals such as Journal of Agricultural and Food Chemistry, International Journal of Food Microbiology and The Analyst.

In The Last Decade

R.F.M. Maas

21 papers receiving 664 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R.F.M. Maas Netherlands 13 369 211 130 107 80 21 695
Imen Ayed‐Boussema Tunisia 17 722 2.0× 317 1.5× 243 1.9× 54 0.5× 32 0.4× 34 1.0k
Jacqueline Van De Walle Belgium 7 289 0.8× 219 1.0× 72 0.6× 45 0.4× 29 0.4× 8 693
Peiqiang Mu China 21 570 1.5× 429 2.0× 161 1.2× 38 0.4× 47 0.6× 40 1.0k
Hassan Amra Egypt 12 432 1.2× 99 0.5× 121 0.9× 25 0.2× 44 0.6× 29 756
Chang Woo Lee South Korea 15 201 0.5× 364 1.7× 62 0.5× 167 1.6× 23 0.3× 36 741
Irene M. Villaseñor Philippines 15 478 1.3× 333 1.6× 68 0.5× 171 1.6× 31 0.4× 39 936
Elisabetta Pastorini Italy 13 417 1.1× 179 0.8× 44 0.3× 33 0.3× 34 0.4× 18 886
Laïla Benbacer Morocco 18 275 0.7× 243 1.2× 92 0.7× 94 0.9× 23 0.3× 57 829
Khan Usmanghani Pakistan 16 358 1.0× 383 1.8× 72 0.6× 141 1.3× 30 0.4× 56 1.0k
Edward M. Croom United States 15 338 0.9× 309 1.5× 39 0.3× 153 1.4× 44 0.6× 35 876

Countries citing papers authored by R.F.M. Maas

Since Specialization
Citations

This map shows the geographic impact of R.F.M. Maas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.F.M. Maas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.F.M. Maas more than expected).

Fields of papers citing papers by R.F.M. Maas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R.F.M. Maas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.F.M. Maas. The network helps show where R.F.M. Maas may publish in the future.

Co-authorship network of co-authors of R.F.M. Maas

This figure shows the co-authorship network connecting the top 25 collaborators of R.F.M. Maas. A scholar is included among the top collaborators of R.F.M. Maas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R.F.M. Maas. R.F.M. Maas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Skálová, Lenka, et al.. (2003). The effects of benzimidazole anthelmintics on P4501A in rat hepatocytes and HepG2 cells. Research in Veterinary Science. 75(1). 61–69. 24 indexed citations
3.
Schaaf, Gerben, Sandra M. Nijmeijer, R.F.M. Maas, et al.. (2002). The role of oxidative stress in the ochratoxin A-mediated toxicity in proximal tubular cells. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1588(2). 149–158. 186 indexed citations
4.
Schaaf, Gerben, R.F.M. Maas, Els M. de Groene, & Johanna Fink‐Gremmels. (2002). Management of Oxidative Stress by Heme Oxygenase-1 in Cisplatin-induced Toxicity in Renal Tubular Cells. Free Radical Research. 36(8). 835–843. 61 indexed citations
5.
Maas, R.F.M., et al.. (2002). Cyclopiazonic acid inhibits mutagenic action of aflatoxin B1. Environmental Toxicology and Pharmacology. 11(3-4). 207–212. 10 indexed citations
6.
Kuilman, M.E.M., R.F.M. Maas, & Johanna Fink‐Gremmels. (2000). Cytochrome P450-mediated metabolism and cytotoxicity of aflatoxin B1 in bovine hepatocytes. Toxicology in Vitro. 14(4). 321–327. 83 indexed citations
7.
Kuilman, M.E.M., et al.. (2000). Inhibition of aflatoxin M1production by bovine hepatocytes after intervention with oltipraz. Veterinary Quarterly. 22(1). 30–35. 11 indexed citations
8.
Maas, R.F.M., et al.. (2000). Effect of fumonisin B1 on rat hepatic P450 system. Environmental Toxicology and Pharmacology. 8(3). 197–204. 16 indexed citations
9.
Kuilman, M.E.M., R.F.M. Maas, Renger F. Witkamp, et al.. (1999). 17alpha-ethyl-5beta-estrane-3alpha, 17beta-diol, a biological marker for the abuse of norethandrolone and ethylestrenol in slaughter cattle. Journal of Chromatography B. 728. 217. 2 indexed citations
10.
Maas, R.F.M., et al.. (1999). Mutagenicity of commercial Monascus fermentation products and the role of citrinin contamination. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 444(1). 7–16. 92 indexed citations
11.
Kuilman, M.E.M., R.F.M. Maas, Renger F. Witkamp, et al.. (1999). 17α-Ethyl-5β-estrane-3α,17β-diol, a biological marker for the abuse of norethandrolone and ethylestrenol in slaughter cattle. Journal of Chromatography B Biomedical Sciences and Applications. 728(2). 217–232. 6 indexed citations
12.
Auerbach, Horst, et al.. (1998). Biodegradation of aflatoxin B1 by bovine rumen microorganisms in vitro and its effects on rumen fermentation. Revue Méd Vét. 149(6). 573. 14 indexed citations
13.
Raus, J., Dirk Vanderzande, J. Gelan, et al.. (1998). In vitro liver models are important tools to monitor the abuse of anabolic steroids in cattle†. The Analyst. 123(12). 2453–2456. 4 indexed citations
14.
Vanderzande, Dirk, et al.. (1998). Identification of some important metabolites of boldenone in urine and feces of cattle by gas chromatography-mass spectrometry†. The Analyst. 123(12). 2681–2686. 36 indexed citations
15.
Maas, R.F.M., et al.. (1998). Bovine Hepatic Metabolism of Aflatoxin B1. Journal of Agricultural and Food Chemistry. 46(7). 2707–2713. 32 indexed citations
17.
Maas, R.F.M., et al.. (1996). Cytochrome P4502E in vivo and in vitro in the dwarf goat: effects of enzyme induction and the applicability of chlorzoxazone as marker substrate. Journal of Veterinary Pharmacology and Therapeutics. 19(3). 245–250. 5 indexed citations
19.
Maas, R.F.M., et al.. (1995). Oral bioavailability and pharmacokinetics of baquiloprim in dwarf goats. Research in Veterinary Science. 58(3). 268–271. 4 indexed citations
20.
Notermans, S., C.J. Heuvelman, R.R. Beumer, & R.F.M. Maas. (1986). Immunological detection of moulds in food: relation between antigen production and growth. International Journal of Food Microbiology. 3(5). 253–261. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026